DIAGNOSTICS ACCELERATOR: DIGITAL BIOMARKERS PROGRAM

ALZHEIMER’S DRUG DISCOVERY FOUNDATION (ADDF)

Object

Topic: Alzheimer.

Destination: Proposed approaches will be evaluated based on the existing evidence around the biological link of the symptom domain to disease and how measuring the proposed symptom domain will improve current screening or monitoring methods in patients.

Budget: Up to $500,000 (higher funding if well justified).

Duration: Not indicated.

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: